Caroline Stout Overview
- Company
- Panacea Acquisit...
- Primary Position
-
Chief Investment...
- Primary Industry
-
Healthcare
- Active Board Seats
-
4
- Med. Deal Size
-
- Med. Valuation
-
Caroline Stout General Information
Biography
Ms. Caroline Stout serves as Chief Investment Officer at Nuvation Bio. She is a Partner at EcoR1 Capital. She serves as a Board Member at Accent Therapeutics. She served as Chief Investment Officer at Panacea Acquisition. She served as a Board Member at Neogene Therapeutics. She graduated magna cum laude from Georgetown University with a Bachelor of Arts in Economics, a Pre-Medical concentration, and a Cognitive Science minor. She also serves as a Board Member at Neogene Therapeutics and Notch Therapeutics. She holds a BA in economics from Georgetown University.
Contact Information
Address
- 357 Tehama Street
- Floor 3
- San Francisco, CA 94103
- United States
Caroline Stout Positions (2)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
EcoR1 Capital | Investor | Partner | San Francisco, CA | Venture Capital | |
Panacea Acquisition II | Company | Chief Investment Officer, Investments | San Francisco, CA | Special Purpose Acquisition Company (SPAC) |
Caroline Stout Board Seats (4)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Accent Therapeutics | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Lexington, MA | |
Affinia Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Waltham, MA | |
Neurogene | Drug Discovery | Publicly Held | Formerly VC-backed | New York, NY | |
Notch Therapeutics | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Vancouver, Canada |
Caroline Stout Lead Partner on Deals (5)
Caroline Stout has been the lead partner on 5 deals. Their latest deal was with Neurogene, a drug discovery company. The deal was made for on 05-Nov-2024.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Neurogene | 05-Nov-2024 | PIPE | Completed | Drug Discovery | New York, NY | |
Accent Therapeutics | 20-Dec-2023 | Completed | Biotechnology | Lexington, MA | ||
Neurogene | 19-Dec-2023 | Completed | Drug Discovery | New York, NY | ||
Affinia Therapeutics | 03-May-2021 | Early Stage VC (Series B) | Completed | Drug Discovery | Waltham, MA | |
Notch Therapeutics | 10-Feb-2021 | Early Stage VC (Series A) | Completed | Biotechnology | Vancouver, Canada |
Caroline Stout Network (89)
Board Members (50)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Raphael Hofstein Ph.D | Notch Therapeutics | Toronto Innovation Acceleration Partners | Vancouver, Canada | |
Diana Brainard MD | Affinia Therapeutics | Self | Waltham, MA | |
Notch Therapeutics | Allogene Therapeutics | Vancouver, Canada | ||
Notch Therapeutics | Notch Therapeutics | Vancouver, Canada | ||
Neogene Therapeutics | Neogene Therapeutics | Santa Monica, CA |
Portfolio Executives (37)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Christine Mikail JD | Neurogene | President and Chief Financial Officer | 05-Nov-2024 | New York, NY |
Michael Cunniffe | Neurogene | Vice President of Finance | 05-Nov-2024 | New York, NY |
Neurogene | General Counsel, Legal & Senior Vice President | 05-Nov-2024 | New York, NY | |
Neurogene | Chief Scientific Officer | 05-Nov-2024 | New York, NY | |
Neurogene | Chief Regulatory Officer | 05-Nov-2024 | New York, NY |
Fund Team Members (2)
Name | Investor | Fund | Fund Location |
---|---|---|---|
EcoR1 Capital | San Francisco, CA | ||
EcoR1 Capital | San Francisco, CA |
Caroline Stout Affiliated Funds (1)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
EcoR1 Venture Opportunity Fund | EcoR1 Capital | Venture - General | Closed | 2019 |
Caroline Stout FAQs
-
Who is Caroline Stout?
Ms. Caroline Stout serves as Chief Investment Officer at Nuvation Bio.
-
How much does Caroline Stout typically invest?
Caroline Stout's median deal size is
. -
What is Caroline Stout’s main position?
Caroline Stout’s primary position is Chief Investment Officer.
-
What are the contact details for Caroline Stout?
Caroline Stout’s email address is ca
and his phone number is +1 (415) . -
How many active board seats does Caroline Stout hold?
Caroline Stout holds 4 board seats including Accent Therapeutics, Affinia Therapeutics, Neurogene, and Notch Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »